Luxottica Group (LUXTY) vs. Its Rivals Head to Head Review

Institutional and Insider Ownership

0.1% of Luxottica Group shares are held by institutional investors. Comparatively, 39.9% of shares of all “Healthcare Equipment & Supplies” companies are held by institutional investors. 75.0% of Luxottica Group shares are held by insiders. Comparatively, 14.8% of shares of all “Healthcare Equipment & Supplies” companies are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Volatility & Risk

Luxottica Group has a beta of 0.27, indicating that its share price is 73% less volatile than the S&P 500. Comparatively, Luxottica Group’s rivals have a beta of 2.49, indicating that their average share price is 149% more volatile than the S&P 500.

Earnings & Valuation

This table compares Luxottica Group and its rivals top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Luxottica Group	$10.34 billion	$1.17 billion	24.37
Luxottica Group Competitors	$1.89 billion	$142.73 million	8.39

Luxottica Group has higher revenue and earnings than its rivals. Luxottica Group is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Dividends

Luxottica Group pays an annual dividend of $0.91 per share and has a dividend yield of 1.6%. Luxottica Group pays out 39.7% of its earnings in the form of a dividend. As a group, “Healthcare Equipment & Supplies” companies pay a dividend yield of 2.3% and pay out 44.0% of their earnings in the form of a dividend.

Profitability

This table compares Luxottica Group and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Luxottica Group	N/A	N/A	N/A
Luxottica Group Competitors	-274.93%	-159.54%	-22.23%

Summary

Luxottica Group beats its rivals on 8 of the 11 factors compared.

About Luxottica Group

Luxottica Group S.p.A., together with its subsidiaries, provides fashion, luxury, sports, and performance eyewear worldwide. It operates through two segments, Manufacturing and Wholesale Distribution, and Retail Distribution. The Manufacturing and Wholesale Distribution segment engages in the design, manufacture, distribution, and marketing of proprietary and designer lines of prescription frames and sunglasses. This segment offers its products under proprietary brands, such as Ray-Ban, Oakley, Persol, Oliver Peoples, Alain Mikli, Arnette, and Vogue Eyewear; and licensed brands, including Giorgio Armani, Emporio Armani, Armani Exchange, Brooks Brothers, Burberry, Bulgari, Chanel, Coach, Dolce&Gabbana, DKNY, Michael Kors, Paul Smith Spectacles, Prada, Miu Miu, Ralph Lauren, Polo Ralph Lauren, Ralph, Starck Eyes, Tiffany & Co, Tory Burch, Valentino, Versace, and Ferrari. The Retail Distribution segment operates prescription eyewear stores primarily under its retail brands, including LensCrafters, Sunglass Hut, Pearle Vision, OPSM, Laubman & Pank, GMO, David Clulow, Salmoiraghi & Viganò, Ray-Ban, Oakley and Vault, Oliver Peoples, Alain Mikli, Ilori Optical, and Optical Shop of Aspen; and licensed brands, such as Sears Optical and Target Optical. As of December 31, 2017, it operated approximately 9,000 stores. The company was founded in 1961 and is headquartered in Milan, Italy. As of October 1, 2018, Luxottica Group S.p.A. operates as a subsidiary of EssilorLuxottica.